AUS
NZ
UK
CA
USA
IND
Healthcare
Lisata Therapeutics Begins Second Cohort Treatment In Bile Duct Cancer Trial
September 17, 2024 12:26 PM EDT| By Team Kalkine MediaLisata Therapeutics Inc,(NASDAQ:LSTA),. has initiated treatment in the second-line cholangiocarcinoma (CCA) cohort of its BOLSTER trial. Cholangiocarcinoma, often referred to as bile duct cancer, is a rare and aggressive cancer with a five-year survi...
Savaria Chief Legal Officer & Corporate Secretary Sylvain Aubry Reduces Holding By 81%
September 16, 2024 03:12 PM EDT| By Team Kalkine MediaSavaria Corporation (,TSX:SIS,), a prominent player in the healthcare sector, has recently seen notable insider transactions. Sylvain Aubry, the Chief Legal Officer & Corporate Secretary, recently sold shares worth CA$415,000 at an average price of C...
Andlauer Healthcare Group Inc.: Financials Remain Robust Despite Recent Stock Weakness
September 13, 2024 02:13 PM EDT| By Team Kalkine MediaRecent performance data for Andlauer Healthcare Group (,TSX:AND,) has shown a 4.8% decline in its stock value over the past week. This decline may raise concerns for stakeholders, but a closer inspection of the company’s financial metrics could provi...
Immunic CEO Highlights New York MS R&D Day and Vidofludimus Calcium in MS Studies
September 13, 2024 07:33 AM EDT| By Team Kalkine MediaImmunic Inc,(NASDAQ:IMUX),recently provided an update on its progress in developing vidofludimus calcium, a promising treatment for multiple sclerosis (MS). CEO Daniel Vitt shared insights into the company's advancements during an interview with Proa...
Limited Concerns About Cardiol Therapeutics' Cash Burn Rate
September 12, 2024 12:50 PM EDT| By Team Kalkine MediaOwning shares in companies that are not yet profitable can be lucrative, as evidenced by Cardiol Therapeutics,(TSX:CRDL),, which has seen a remarkable 136% increase in its share price over the past year. This impressive gain highlights the potential...
Risks Remain Elevated as Nova Leap Health Corp. Shares Drop 27%
September 12, 2024 06:47 AM EDT| By Team Kalkine MediaNova Leap Health Corp.,(TSXV:NLH),has recently faced a substantial drop in its share price, with a decline of 27% over the past thirty days. Despite this, the stock has shown resilience over a longer timeframe, rising by 21% over the last year. This...
Improved Revenues Needed for iAnthus Capital Holdings, Inc. Stock's Recent Surge to Be Justified
September 10, 2024 02:47 PM EDT| By Team Kalkine MediaiAnthus Capital Holdings, Inc.,(OTH:ITHUF),has recently demonstrated impressive performance, with its share price showing a notable 33% gain over the past month. This uptick marks a significant recovery from previous declines. Despite this positive s...
Cardiol Therapeutics to Present Results from Phase 2 Recurrent Pericarditis Study
September 10, 2024 01:53 PM EDT| By Team Kalkine MediaCardiol Therapeutics,(TSX:CRDL),has completed its Phase 2 MAvERIC-Pilot study evaluating the effects of its novel therapy, CardiolRx, on patients with recurrent pericarditis. The company plans to present the comprehensive results at the American Hear...
Is WELL Health Technologies a High-Risk Opportunity?
September 09, 2024 02:16 PM EDT| By Team Kalkine MediaHoward Marks eloquently highlighted the primary concern in financial management: “The possibility of permanent loss is the risk I worry about... and every practical individual I know worries about.” When evaluating a company’s financial stability, as...
Risks and Challenges for Lifeist Wellness in the Healthcare Sector
September 06, 2024 03:03 PM EDT| By Team Kalkine MediaThe,healthcare sector,has recently seen significant fluctuations, impacting various companies including Lifeist Wellness Inc. Lifeist Wellness, listed on the TSX Venture Exchange, has garnered attention due to its performance and market conditions. H...
Voyageur Pharmaceuticals Advances Diagnostic Products Toward FDA Approval
September 05, 2024 03:43 PM EDT| By Team Kalkine MediaIn the,Healthcare sector,, Voyageur Pharmaceuticals has reached a significant milestone with the completion of its innovative diagnostic product formulations. This development marks a crucial step as the company prepares to seek approval from the U.S...
Evaluating Risk Factors for TerrAscend Inc.
September 03, 2024 10:30 AM EDT| By Team Kalkine MediaTerrAscend Inc. operates within the,Healthcare sector,, focusing on cannabis and related products. An evaluation of the company's financial stability and operational performance provides insight into its risk profile.,Company Performance and Risk Ass...
Assessing the Financial Health of Microbix Biosystems
August 22, 2024 12:00 AM EDT| By Team Kalkine MediaMicrobix Biosystems Inc., operating within the,Healthcare sector,, has recently drawn attention due to its earnings performance. Stakeholders are urged to take a closer look at the company’s financial results to better understand its current position...
A Look at Dividends in a Leading Senior Care Stock
August 21, 2024 12:00 AM EDT| By Team Kalkine MediaThe,healthcare sector,, particularly senior housing and care services, continues to be a significant focus in Canada due to the country's aging population. This environment supports companies like Extendicare , which operates within this sector and o...
_08_21_2024_18_53_21_714285.jpg)
CanSortium Inc. CEO Compensation Draws Attention in Healthcare Sector
August 21, 2024 12:00 AM EDT| By Team Kalkine MediaCanSortium Inc., a company within the,Healthcare sector,, has recently drawn attention due to the review of its CEO's compensation. This analysis provides a closer look at the financial arrangements of key executives and their alignment with company...
Trulieve Cannabis Reports Q2 2024 Earnings
August 09, 2024 10:20 AM EDT| By Team Kalkine MediaFor the second quarter of 2024, Trulieve Cannabis,(TSX:TRUL),reported revenue of US$303.4 million, marking a 7.7% increase compared to the same period in 2023. Despite this growth, the company reported a net loss of US$10.7 million, although this los...
Cresco Labs Inc. Transitions from Loss to Profit
August 09, 2024 10:15 AM EDT| By Team Kalkine MediaCresco Labs,(TSX:CL),, the company is anticipated to reach breakeven soon. Cresco Labs will incur a final loss in 2024 but will achieve positive profits of $15 million in 2025. This projection suggests the company is expected to breakeven just over a...
Bausch Health (TSX:BHC) Refutes Bankruptcy Rumors Following Reorg® Article
July 25, 2024 03:33 AM EDT| By Team Kalkine MediaBausch Health Companies Inc. (NYSE/,TSX:BHC,) has issued a statement to address and refute recent rumors circulating in a news article published by Reorg®. The article, which cited unnamed sources, suggested that the company might be considering a ba...
Bausch Health (NYSE/TSX: BHC) Appoints New Executives to Strengthen Leadership Team
July 22, 2024 02:38 AM EDT| By Team Kalkine MediaBausch Health Companies Inc. (NYSE/,TSX: BHC,) has announced the appointment of two seasoned executives to its Executive Leadership Team (ELT), effective in the coming months.,Jean-Jacques Charhon Appointed CFO,Jean-Jacques Charhon, known as "JJ," wi...
What's the Scoop on WELL Health Stock?
June 03, 2024 06:38 AM EDT| By Team Kalkine MediaWELL Health Technologies (TSX: WELL,) has delivered another record-breaking quarter, propelling its shares up by approximately 8% following the earnings report. Despite these impressive earnings, the company's stock remains significantly below its 52...
